Trade Summary

1 month ago, Ra Capital Management, L.P., serving as 10% owner at Hemab Therapeutics Holdings, Inc. (COAG), purchased 51,258 shares at $24.75 per share, for a total transaction value of $1,268,594.00. Following this transaction, Ra Capital Management, L.P. now holds 7,729,773 shares of COAG.

This purchase represents a 1.00% increase in Ra Capital Management, L.P.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, May 7, 2026 and publicly disclosed via SEC Form 4 filing on Monday, May 11, 2026 at 5:44 PM ET, 4 days after the trade was made.

Hemab Therapeutics Holdings, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.